Additionally, the integrative Onco Genomics analysis (intOgen https://www.intogen.org/search, accessed on 2 December 2020), which evaluated the mutational status in 28,076 samples of 66 cancer types, acknowledged different mutations in PAK1, RASSF4, DVL1 and HIPK2 genes. The gene discussed is RASSF4; the disease is cancer.